stockportfolio.pro
Regeneron Pharmaceuticals, Inc. Shares Outstanding 2008–2025
Regeneron Pharmaceuticals, Inc. (REGN) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 0.0M | — |
| FY 2024 | 0.0M | — |
| FY 2023 | 0.0M | — |
| FY 2022 | 0.0M | — |
| FY 2021 | 0.0M | — |
| FY 2020 | 0.0M | — |
| FY 2019 | 0.0M | — |
| FY 2018 | 0.0M | — |
| FY 2017 | 0.0M | — |
| FY 2016 | 0.0M | — |
| FY 2015 | 0.0M | — |
| FY 2014 | 0.0M | — |
| FY 2013 | 0.0M | — |
| FY 2012 | 0.0M | -100.0% |
| FY 2011 | 90.7M | +4.0% |
| FY 2010 | 87.2M | +10.6% |
| FY 2009 | 78.9M | — |
| FY 2008 | 0.0M | — |
Source: Regeneron Pharmaceuticals, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Regeneron Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeRegeneron Pharmaceuticals, Inc. — frequently asked questions
What is Regeneron Pharmaceuticals, Inc.'s shares outstanding?
Regeneron Pharmaceuticals, Inc. (REGN) reported shares outstanding of 0.0M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Regeneron Pharmaceuticals, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.